← Eichor
Study identifier: NCT05775523 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Condition: Growth Hormone Deficiency  ·  Sponsor: Ascendis Pharma Endocrinology Division A/S

PhaseN/A
Planned participants500
Who can joinAll sexes, 1 Year to 18 Years
Healthy volunteersNo

About this study

The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.

This description comes directly from the study's public registry record.

Talk to the study team

Deborah Bowlby  ·  +1 844-442-7236  ·  SkyPASS_Contact@ascendispharma.com

Always discuss trial participation with your own doctor first.

Locations (27)

Ascendis Investigational SitePhoenix, Arizona, United StatesRecruiting
Ascendis Investigational SiteOrange, California, United StatesRecruiting
Ascendis Investigational SiteSacramento, California, United StatesRecruiting
Ascendis Investigational SiteSan Francisco, California, United StatesRecruiting
Ascendis Pharma Investigational SiteCentennial, Colorado, United StatesRecruiting
Ascendis Investigational SiteWashington D.C., District of Columbia, United StatesRecruiting
Ascendis Investigational SiteOrlando, Florida, United StatesRecruiting
Ascendis Investigational SiteOrlando, Florida, United StatesRecruiting
Ascendis Investigational SiteTampa, Florida, United StatesRecruiting
Ascendis Investigational SiteSandy Springs, Georgia, United StatesRecruiting
Ascendis Investigational SiteBoise, Idaho, United StatesRecruiting
Ascendis Investigational SiteIndianapolis, Indiana, United StatesRecruiting

+ 15 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05775523